AMGN

Amgen Inc.

  • sector: Healthcare
  • exchange: NASDAQ
  • in 4 Arithmos indices

Indices that include AMGN 4/4

sort
weight≥ 0.0%
alongside
  1. #1

    Recession-Resilient US Defensive 20 — Equal-Weighted

    AMGN · 5.00%JNJABBVUNHMRK+15 more

    Established biotech with mature product portfolio in oncology and inflammation; 71% gross margin and 2.9% dividend yield reflect strong cash generation despite higher leverage. Equal-weighted per user specification.

    CAGR
    8.6%
    Sharpe
    0.57
    max DD
    -26.3%
  2. #2

    Recession-Resilient US Defensive 20 — Equal-Weighted

    AMGN · 5.00%PGKOPEPCL+15 more

    Leading biotech with $186B market cap, 71% gross margin, and 8.6% revenue growth. Equal-weighted at 5%; established biologics portfolio supports strong free cash flow generation.

    CAGR
    2.5%
    Sharpe
    0.20
    max DD
    -14.2%
  3. #3

    Longevity & Healthspan Index

    AMGN · 7.00%UNITYEXASILMNVCNX+7 more

    AMG 133 weight-loss bispecific + bone-density agents for age-related musculoskeletal decline.

    CAGR
    –
    Sharpe
    –
    max DD
    –
  4. #4

    GLP-1 Obesity Boom Index

    AMGN · 10.00%LLYNVOVKTXZBH+3 more

    MariTide bispecific weight-loss with monthly dosing potential.

    CAGR
    –
    Sharpe
    –
    max DD
    –

Build your own index that includes AMGN.

Write a plain-English prompt, get transparent rules and a 10-year backtest.

start a prompt →

Performance figures are simulated backtests, not live returns. Past performance does not predict future results. Arithmos is a research and data tool, not investment advice.

/home·/markets·/feed·/leaderboard·/sharpe·/blog·/pricing·/about·/vacancies·/contact·/links·/terms
⚠Investment research & data tool · not investment advice · not a regulated broker or advisor · past performance does not guarantee future results.